华润医药2026年第一季度营收18.14亿元,经调整净利润4.55亿元

公告速递
Apr 24

本季度信息

截至2026年3月31日,华润医药实现营收18.14亿元,同比增长约5.50%。经调整净利润4.55亿元,同比增长约7.11%。报告期内,现金及现金等价物净增加额为12.15亿元,相较上一年同期的3.91亿元增幅约211%。期末现金及现金等价物余额达46.21亿元。

同时,总资产为135.52亿元,总负债为27.13亿元。上述财务数据由华润医药的附属公司东阿阿胶股份有限公司根据中国公认会计准则编制并披露。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10